StemBioSys
PrivateLast Round
Series C
Extension
Jun 5, 2024
Est. Valuation
$52.95M
Total Funding Raised
$20.8M
Company Overview
StemBioSys is a biotechnology company that develops cell-matrix technologies designed for the enhanced isolation, growth, and delivery of stem cells for research, diagnostic, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemBioSys Comparables
Compare StemBioSys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioLamina AB | 83% | |
| Xylyx Bio | 79% | |
| Bio-Techne Corporation | 77% | |
StemBioSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 5, 2024 | ||||
| Series C | Aug 1, 2021 | ||||
| Grant | Apr 30, 2019 | ||||
| Grant | Apr 30, 2019 | ||||
| Series B | May 24, 2018 | ||||
Series A | Apr 14, 2015 |
StemBioSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VelocityTX | Pre Seed |
| National Institute on Aging | Grant |
| National Institute of Environmental Health Sciences | Grant |
| Targeted Technology | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2025
Monthly visitors grew 108% MoM, reaching 2.5K.
- Nov 24, 2024
Monthly visitors grew 93% MoM, reaching 2.7K.
StemBioSys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about StemBioSys's valuation, stock price, and market status.